🔬 La semana pasada, PROALT patrocinó en la @urjc el evento “Hacia la medicina de precisión en cáncer de colon”, con participación de Custodia García Jiménez, José Manuel González Sancho, Rocío Díaz Sánchez, Natalia Pendás Franco y nuestro CEO, Juan Ignacio Imbaud.
👉
96
🚀 Protein Alternatives will be be presenting at #BioTrinity2025 in Science Track 1!
📅 April 2 | 🕝 14:30-16:00
🔬 Science Spotlight Thirteen – New Platforms & Technologies for Drug Discovery
See you in London! ✨
#DrugDiscovery #Biotech #Innovation #ProteinAlternatives
14
Protein Alternatives Welcomes Dr Antoni Castells Garangou, MD, PhD, to our Scientific Advisory Board
proteinalternatives.com/prot…
#Welcome #Oncology #ProteinAlternatives
12
Protein Alternatives Welcomes Prof. Eric Van Cutsem, MD, PhD, to our Scientific Advisory Board
proteinalternatives.com/prot…
#Welcome #Oncology #ProteinAlternatives
12
Protein Alternatives welcomes back Hugo Cartagena in his new role as COO
proteinalternatives.com/prot…
#WelcomeBack #Biotechnology #ProteinAlternatives
16
ProAlt was selected by the European Innovation Council (@EUeic) to participate in the EIC Corporate Day with Merck (@merckgroup)
Protein Alternatives testará anticuerpos monoclonales frente al motivo RGD como un nuevo enfoque para el tratamiento de la COVID-19
linkedin.com/feed/update/urn…
#COVID19 #SARSCoV2 #coronavirus #Antibodies
Anti RGD-motif monoclonal antibodies in development by Protein Alternatives (Proalt) will be tested as a new approach to treat COVID-19
linkedin.com/feed/update/urn…
#COVID19 #SARSCoV2 #coronavirus #antibodies
Today we are in the Biomedical Innovation Summit #BISMadrid #profesionales #protein #antibody #bio #Madrid
#WorldCancerDay PROALT: Colorectal cancer diagnostic and therapeutic antibodies.










